OFINEXT 100% part of the Ofichem Group
Tuesday 4 August 2020
- Life Cooperative
Last year, Lab Ofichem set up a new Business Unit, Ofinext, through a joint venture. Ofichem Group can now announce that Ofinext has been completely taken over by Lab Ofichem and has therefore become a 100% part of the Ofichem Group.
Ofinext is fully engaged in producing full spectrum cannabis extracts as an Active Pharmaceutical Ingredient (API) for the pharmaceutical industry. The extract is obtained using a unique extraction technology under GMP guidelines. The technique allows valuable ingredients of the plant to be retained in the extract after the process. This is in contrast to other common extraction techniques.
“We consider it important to continue investing in this. We are therefore delighted with this strategic step and acquisition of the 100% shares.” – Weite Oldenziel, CEO Ofichem Group.
This acquisition does not bring any noticeable changes to customers as production. Read more via Ofichem.
Source: Ofichem.
Image: Ofinext
Focus areas
Life CooperativeLatest news
-
Thursday 5 November 2020
Start-up Reperio developing diagnostic technology for glau..
-
Monday 21 September 2020
Campus ecosystem invests in SG Papertronics
-
Wednesday 16 September 2020
First patients treated in First-in-Human Trial for Polygan..
-
Tuesday 15 September 2020
InnoCore Pharmaceuticals to develop long-acting injectable..
-
Wednesday 9 September 2020
Agreement signed for new Innovation Center Chemistry and E..
-
Wednesday 2 September 2020
Campus Community Fund invests 500 million euros in Campus ..
-
Thursday 6 August 2020
Pharma Connect Capital invests in Hercules Pharmaceuticals..
-
Friday 26 June 2020
On the way to 'one size fits all' tracer
-
Wednesday 10 June 2020
QPS hopeful about drug for corona patients
-
Tuesday 9 June 2020
MercachemSyncom: de kracht van de synergie

English
Nederlands